[Ulipristal acetate, 5mg: a new alternative].

Author: FusterSonia, HiguerasGema, Monleón SanchoJavier, MorcilloInmaculada, RomagueraEugenia, RomeroAinhoa

Paper Details 
Original Abstract of the Article :
Fibroids have a high prevalence (approaching 50%) in the female population. Although they are a benign entity, they represent a health problem of considerable magnitude, causing hemorrhaging, pain and sterility. Surgical treatment is currently safe and effective, but in recent decades numerous less ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/S0025-7753(13)70052-6

データ提供:米国国立医学図書館(NLM)

A New Oasis in the Desert of Fibroid Treatment: Ulipristal Acetate

Fibroids, like stubborn sand dunes in the desert, can pose significant challenges to women's health. This study, like a group of researchers exploring new pathways in the desert of fibroid treatment, investigates the efficacy and safety of ulipristal acetate (UA) as a potential new alternative. The researchers examined the existing literature on UA, a selective progesterone receptor modulator (SPRM), and its impact on fibroid size, uterine volume, and bleeding control. They found that UA effectively reduced fibroid size and uterine volume, leading to decreased bleeding and improved symptoms. UA also induced amenorrhea in most patients, offering a potential option for managing menstrual irregularities associated with fibroids.

Ulipristal Acetate: A Promising New Oasis

The study's findings suggest that UA is a promising new treatment option for fibroids. It effectively reduces fibroid size and uterine volume, leading to decreased bleeding and improved symptoms. UA also induces amenorrhea in most patients, offering a potential solution for managing menstrual irregularities associated with fibroids.

Navigating the Desert of Fibroid Treatment

This research highlights the importance of exploring new and less invasive treatment options for fibroids. The study's findings suggest that UA might be a valuable tool in the management of fibroids, offering a safe and effective alternative to traditional surgical interventions.

Dr. Camel's Conclusion

The desert of fibroid treatment continues to evolve, seeking new oases of relief for women struggling with these challenging conditions. Ulipristal acetate emerges as a potential oasis, offering a safe and effective treatment option for reducing fibroid size, controlling bleeding, and inducing amenorrhea. This research represents a significant advancement in the management of fibroids, offering hope for a more comfortable and manageable journey through the desert of fibroid-related health challenges.

Date :
  1. Date Completed 2014-08-18
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

24314567

DOI: Digital Object Identifier

10.1016/S0025-7753(13)70052-6

Related Literature

SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.